Small molecule: protein degraders companies

As of Oct 2026, Radar classifies 33 companies as Small molecule: protein degraders; 4 of them have job postings observed in our sources.

Draft page: not yet published to search engines (owner review pending).

Dots are city centers, sized by number of companies. Largest: Watertown, MA 2; Wilmington, DE 1; Brisbane, CA 1; San Diego, CA 1; King Of Prussia, PA 1. Map: US Census.

Companies

Bristol-Myers Squibb FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Bispecific antibodies, Cell therapy, Cell therapy: CAR-T · 712 jobs observed · 1560 trials (lead sponsor)
Nurix Therapeutics Clinical Phase 3
Brisbane, CA · Small molecule: protein degraders, Small molecule · 46 jobs observed · 10 trials (lead sponsor)
Kymera Therapeutics, Inc. Clinical Phase 2
Watertown, MA · Small molecule: protein degraders, Small molecule · 25 jobs observed · 12 trials (lead sponsor)
Magnet Biomedicine
Small molecule: protein degraders, Small molecule · 732 jobs observed
Alaw Therapeutics
AI drug discovery, Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Avilar Therapeutics
Watertown, MA · Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Cothera Bioscience FDA-cleared device company Clinical Phase 2
Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 1 trial (lead sponsor)
Cullgen
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Degron Therapeutics Clinical Phase 1
Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 1 trial (lead sponsor)
Eilean Therapeutics Clinical Phase 1
Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 5 trials (lead sponsor)
Fortitude Biomedicines
Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources
Kazia Therapeutics Limited
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Larkspur Biosciences Clinical Phase 2
Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 1 trial (lead sponsor)
Lomond Therapeutics
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Monte Rosa Therapeutics, Inc
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Neomorph Clinical Phase 1
AI drug discovery, Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 1 trial (lead sponsor)
NiKang Therapeutics Clinical Phase 2
Wilmington, DE · Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 5 trials (lead sponsor)
Origami Therapeutics, Inc.
San Diego, CA · Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Photys Therapeutics
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Plexium Clinical Phase 1
Gene editing: CRISPR, Gene editing, Small molecule: protein degraders · No hiring observed in our sources · 1 trial (lead sponsor)
Progenra Inc.
Malvern, PA · Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Ranok Therapeutics
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
Seed Therapeutics Clinical Phase 1
King Of Prussia, PA · Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 1 trial (lead sponsor)
Stablix Therapeutics
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
TRIANA Biomedicines, Inc. Clinical Phase 2
Small molecule: protein degraders, Small molecule · No hiring observed in our sources · 1 trial (lead sponsor)
VRise Therapeutics
Small molecule: protein degraders, Small molecule · No hiring observed in our sources
YDS Pharmatech
Albany, NY · Small molecule: protein degraders, Small molecule · No hiring observed in our sources

Showing 33 of 33. Filter in Discover